RT Journal Article
T1 Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection.
A1 Hernández Camba, Alejandro
A1 Ramos, Laura
A1 Madrid Álvarez, María Blanca
A1 Pérez-Méndez, Lina
A1 Nos, Pilar
A1 Hernández, Vicent
A1 Guerra, Ivan
A1 Jiménez, Nuria
A1 Lorente, Rufo
A1 Sierra-Ausín, Mónica
A1 Ginard, Daniel
A1 Varela Trastoy, Pilar
A1 Arranz, Laura
A1 Cabello Tapia, María José
A1 Zabana, Yamile
A1 Barreiro-de Acosta, Manuel
A1 GETECCU, 
K1 Ansiedad
K1 Anxiety
K1 COVID-19
K1 Confinamiento
K1 DASS-21
K1 Depresión
K1 Depression
K1 EII
K1 Estrés
K1 IBD
K1 Lockdown
K1 Pandemia
K1 Pandemic
K1 Stress
AB This multicenter cross-sectional study was conducted to assess the psychosocial impact of COVID-19 on patients with inflammatory bowel disease (IBD) in Spain during lockdown and the first wave of the pandemic. A self-report questionnaire that integrated the Spanish version of the Depression, Anxiety and Stress Scale-21 items (DASS-21) and the Perceived Stress Questionnaire (PSS) was designed to gather sociodemographic data and information related to the effects of lockdown on the lives of IBD patients. Twelve IBD units invited their patients to answer the anonymous online survey between the 1st July and the 25th August 2020. Of the 693 survey participants with IBD, 67% were women and the mean age was 43 (SD 12). Sixty-one percent had ulcerative colitis, 36% Crohn's disease and 3% indeterminate colitis. DASS-21 scores indicate that during lockdown the estimated prevalence of depression was 11% [95% CI 8.2-13%], anxiety 20% [95% CI 17 to 23%] and stress 18% [95% CI 8.2-13%]. Multivariate analysis showed that the perceived high risk of COVID-19 infection because of having IBD and maladaptation to government measures to reduce the spread of disease doubled the risk of anxiety and stress during lockdown. In the short-term, lockdown during the COVID-19 pandemic seemed to have an impact on the already affected mental health of our IBD patients in Spain.
YR 2021
FD 2021-09-22
LK https://hdl.handle.net/10668/26257
UL https://hdl.handle.net/10668/26257
LA en
LA es
DS RISalud
RD Apr 6, 2025